cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc26dhty
title: CCDC 2037810: Experimental Crystal Structure Determination

description: Related Article: Pierre Thuery, Jack Harrowfield|2021|Inorg.Chem.|60|1683|doi:10.1021/acs.inorgchem.0c03205
DOI: 10.5517/ccdc.csd.cc26dhvz
title: CCDC 2037811: Experimental Crystal Structure Determination

description: Related Article: Pierre Thuery, Jack Harrowfield|2021|Inorg.Chem.|60|1683|doi:10.1021/acs.inorgchem.0c03205
DOI: 10.5517/ccdc.csd.cc26dhw0
title: CCDC 2037812: Experimental Crystal Structure Determination

description: Related Article: Pierre Thuery, Jack Harrowfield|2021|Inorg.Chem.|60|1683|doi:10.1021/acs.inorgchem.0c03205
DOI: 10.5517/ccdc.csd.cc26dhx1
title: CCDC 2037813: Experimental Crystal Structure Determination

description: Related Article: Pierre Thuery, Jack Harrowfield|2021|Inorg.Chem.|60|1683|doi:10.1021/acs.inorgchem.0c03205
DOI: 10.5517/ccdc.csd.cc26dhy2
title: CCDC 2037814: Experimental Crystal Structure Determination

description: Related Article: Pierre Thuery, Jack Harrowfield|2021|Inorg.Chem.|60|1683|doi:10.1021/acs.inorgchem.0c03205
DOI: 10.5517/ccdc.csd.cc26dhz3
title: CCDC 2037815: Experimental Crystal Structure Determination

description: Related Article: Pierre Thuery, Jack Harrowfield|2021|Inorg.Chem.|60|1683|doi:10.1021/acs.inorgchem.0c03205
DOI: 10.5517/ccdc.csd.cc26fv4n
title: CCDC 2039091: Experimental Crystal Structure Determination

description: Related Article: Xue-Song Li, Dan-tong Xu, Zhi-Jie Niu, Ming Li, Wei-Yu Shi, Cui-Tian Wang, Wan-Xu Wei, Yong-Min Liang|2021|Org.Lett.|23|832|doi:10.1021/acs.orglett.0c04070
DOI: 10.5517/ccdc.csd.cc26gn1d
title: CCDC 2039863: Experimental Crystal Structure Determination

description: Related Article: Nadine Bönisch, Mariia Maliuta, Irena Senkovska, Volodymyr Bon, Petko Petkov, Christel Plätzer, Philipp Müller, Stefan Kaskel|2021|Inorg.Chem.|60|1726|doi:10.1021/acs.inorgchem.0c03218
DOI: 10.5517/ccdc.csd.cc26gn2f
title: CCDC 2039864: Experimental Crystal Structure Determination

description: Related Article: Nadine Bönisch, Mariia Maliuta, Irena Senkovska, Volodymyr Bon, Petko Petkov, Christel Plätzer, Philipp Müller, Stefan Kaskel|2021|Inorg.Chem.|60|1726|doi:10.1021/acs.inorgchem.0c03218
DOI: 10.5517/ccdc.csd.cc26gn3g
title: CCDC 2039865: Experimental Crystal Structure Determination

description: Related Article: Nadine Bönisch, Mariia Maliuta, Irena Senkovska, Volodymyr Bon, Petko Petkov, Christel Plätzer, Philipp Müller, Stefan Kaskel|2021|Inorg.Chem.|60|1726|doi:10.1021/acs.inorgchem.0c03218
DOI: 10.5517/ccdc.csd.cc26gt6q
title: CCDC 2040023: Experimental Crystal Structure Determination

description: Related Article: Jie Feng, Hui Liu, Yun Yao, Chong-Dao Lu|2021|J.Org.Chem.|86|3049|doi:10.1021/acs.joc.0c02583
DOI: 10.5517/ccdc.csd.cc26gt7r
title: CCDC 2040024: Experimental Crystal Structure Determination

description: Related Article: Jie Feng, Hui Liu, Yun Yao, Chong-Dao Lu|2021|J.Org.Chem.|86|3049|doi:10.1021/acs.joc.0c02583
DOI: 10.5517/ccdc.csd.cc26gt8s
title: CCDC 2040025: Experimental Crystal Structure Determination

description: Related Article: Jie Feng, Hui Liu, Yun Yao, Chong-Dao Lu|2021|J.Org.Chem.|86|3049|doi:10.1021/acs.joc.0c02583
DOI: 10.5517/ccdc.csd.cc250knf
title: CCDC 1996544: Experimental Crystal Structure Determination

description: Related Article: Yongzhuang Wang, Xiaoli Huang, Qin Wang, Yuhai Tang, Silong Xu, Yang Li|2021|Org.Lett.|23|757|doi:10.1021/acs.orglett.0c03982
DOI: 10.5517/ccdc.csd.cc26rvkd
title: CCDC 2048714: Experimental Crystal Structure Determination

description: Related Article: Qiao-Fei Bao, Ming Li, Yu Xia, Yu-Zhao Wang, Zhao-Zhao Zhou, Yong-Min Liang|2021|Org.Lett.|23|1107|doi:10.1021/acs.orglett.1c00034
DOI: 10.5517/ccdc.csd.cc26rvqk
title: CCDC 2048719: Experimental Crystal Structure Determination

description: Related Article: Qiao-Fei Bao, Ming Li, Yu Xia, Yu-Zhao Wang, Zhao-Zhao Zhou, Yong-Min Liang|2021|Org.Lett.|23|1107|doi:10.1021/acs.orglett.1c00034
DOI: 10.5517/ccdc.csd.cc26rvzt
title: CCDC 2048727: Experimental Crystal Structure Determination

description: Related Article: Yilin Chen, Jiancheng Li, Yiling Zhao, Li Zhang, Gengwen Tan, Hongping Zhu, Herbert W. Roesky|2021|J.Am.Chem.Soc.|143|2212|doi:10.1021/jacs.0c12908
DOI: 10.5517/ccdc.csd.cc26rw0w
title: CCDC 2048728: Experimental Crystal Structure Determination

description: Related Article: Yilin Chen, Jiancheng Li, Yiling Zhao, Li Zhang, Gengwen Tan, Hongping Zhu, Herbert W. Roesky|2021|J.Am.Chem.Soc.|143|2212|doi:10.1021/jacs.0c12908
DOI: 10.5281/zenodo.4539693
title: mosartwmpy validation data 1981 - 1982

description: Validation data for testing the mosartwmpy model: https://github.com/IMMM-SFA/mosartwmpy
DOI: 10.6084/m9.figshare.13805258
title: Decreased microstructural integrity of the central somatosensory tracts in diabetic peripheral neuropathy

description: supplemental tables
DOI: 10.6084/m9.figshare.13805258.v2
title: Decreased microstructural integrity of the central somatosensory tracts in diabetic peripheral neuropathy

description: supplemental tables
DOI: 10.6084/m9.figshare.13805258.v1
title: Decreased microstructural integrity of the central somatosensory tracts in diabetic peripheral neuropathy

description: supplemental tables
DOI: 10.5281/zenodo.4539732
title: Natural history specimens collected and/or identified and deposited.

description: Natural history specimen data collected and/or identified by Maryzender Rodríguez-Melgarejo, https://orcid.org/0000-0002-3516-4270. Claims were made on Bionomia, https://bionomia.net using specimen data from the Global Biodiversity Information Facility, https://gbif.org.
DOI: 10.5281/zenodo.4539731
title: Natural history specimens collected and/or identified and deposited.

description: Natural history specimen data collected and/or identified by Maryzender Rodríguez-Melgarejo, https://orcid.org/0000-0002-3516-4270. Claims were made on Bionomia, https://bionomia.net using specimen data from the Global Biodiversity Information Facility, https://gbif.org.
DOI: 10.6084/m9.figshare.13978499
title: Additional file 1 of Author Correction: Assembly of hundreds of novel bacterial genomes from the chicken caecum

description: Additional file 5 A: Clustering of samples at 60% AAI to form genus clusters. Novel genera were defined as clusters of MAGs at 60% AAI which were not assigned a genus by GTDB-Tk. B: Protologues for the new Candidatus names.
DOI: 10.6084/m9.figshare.13978499.v1
title: Additional file 1 of Author Correction: Assembly of hundreds of novel bacterial genomes from the chicken caecum

description: Additional file 5 A: Clustering of samples at 60% AAI to form genus clusters. Novel genera were defined as clusters of MAGs at 60% AAI which were not assigned a genus by GTDB-Tk. B: Protologues for the new Candidatus names.
DOI: 10.6084/m9.figshare.13978501
title: Additional file 1 of Evidence for the effects of decommissioning man-made structures on marine ecosystems globally: a systematic map protocol

description: Additional file 1: Authors’ declaration and checklist of adherence to the ROSES guidelines.
DOI: 10.6084/m9.figshare.13978504.v1
title: Additional file 2 of Evidence for the effects of decommissioning man-made structures on marine ecosystems globally: a systematic map protocol

description: Additional file 2: Building and testing the search string against a list of benchmark publications.
DOI: 10.6084/m9.figshare.13978501.v1
title: Additional file 1 of Evidence for the effects of decommissioning man-made structures on marine ecosystems globally: a systematic map protocol

description: Additional file 1: Authors’ declaration and checklist of adherence to the ROSES guidelines.
DOI: 10.6084/m9.figshare.13978510
title: Additional file 4 of Evidence for the effects of decommissioning man-made structures on marine ecosystems globally: a systematic map protocol

description: Additional file 4: Working framework for meta-data coding.
DOI: 10.6084/m9.figshare.13978504
title: Additional file 2 of Evidence for the effects of decommissioning man-made structures on marine ecosystems globally: a systematic map protocol

description: Additional file 2: Building and testing the search string against a list of benchmark publications.
DOI: 10.6084/m9.figshare.13978510.v1
title: Additional file 4 of Evidence for the effects of decommissioning man-made structures on marine ecosystems globally: a systematic map protocol

description: Additional file 4: Working framework for meta-data coding.
DOI: 10.5517/ccdc.csd.cc22h8hc
title: CCDC 1921302: Experimental Crystal Structure Determination

description: Related Article: Yu Zhu, Dong-Sheng Li, Jian Zhang, Lei Zhang|2021|Inorg.Chem.|60|1985|doi:10.1021/acs.inorgchem.0c03448
DOI: 10.5517/ccdc.csd.cc26pth7
title: CCDC 2046759: Experimental Crystal Structure Determination

description: Related Article: Yu Zhu, Dong-Sheng Li, Jian Zhang, Lei Zhang|2021|Inorg.Chem.|60|1985|doi:10.1021/acs.inorgchem.0c03448
DOI: 10.5517/ccdc.csd.cc271rtw
title: CCDC 2057278: Experimental Crystal Structure Determination

description: Related Article: Yilin Chen, Jiancheng Li, Yiling Zhao, Li Zhang, Gengwen Tan, Hongping Zhu, Herbert W. Roesky|2021|J.Am.Chem.Soc.|143|2212|doi:10.1021/jacs.0c12908
DOI: 10.6084/m9.figshare.13978547
title: Additional file 3 of MSN, MWCNT and ZnO nanoparticle-induced CHO-K1 cell polarisation is linked to cytoskeleton ablation

description: Additional file 3: Table S2. Comparative proteomic profile of MSN15, ZnO5 and MWCNT5 NPs.
DOI: 10.6084/m9.figshare.13978547.v1
title: Additional file 3 of MSN, MWCNT and ZnO nanoparticle-induced CHO-K1 cell polarisation is linked to cytoskeleton ablation

description: Additional file 3: Table S2. Comparative proteomic profile of MSN15, ZnO5 and MWCNT5 NPs.
DOI: 10.6084/m9.figshare.13978550
title: Additional file 4 of MSN, MWCNT and ZnO nanoparticle-induced CHO-K1 cell polarisation is linked to cytoskeleton ablation

description: Additional file 4: Table S3. Gene Ontology analysis in response to MSN15, ZnO5 and MWCNT5 NPs: Only differentially regulated proteins were subject to Gene Ontology (GO) analysis. These Table show the up- and down-regulated GO terms for cellular component, biological process, molecular function and pathway of the proteins.
DOI: 10.6084/m9.figshare.13978550.v1
title: Additional file 4 of MSN, MWCNT and ZnO nanoparticle-induced CHO-K1 cell polarisation is linked to cytoskeleton ablation

description: Additional file 4: Table S3. Gene Ontology analysis in response to MSN15, ZnO5 and MWCNT5 NPs: Only differentially regulated proteins were subject to Gene Ontology (GO) analysis. These Table show the up- and down-regulated GO terms for cellular component, biological process, molecular function and pathway of the proteins.
DOI: 10.6084/m9.figshare.13978603
title: Additional file 6 of CHICKN: extraction of peptide chromatographic elution profiles from large scale mass spectrometry data by means of Wasserstein compressive hierarchical cluster analysis

description: Additional file 6: Consensus chromatogram stability. A set of 10 figures exemplifying the stability of the pre-image computation through the averaging of a neighborhood of varying size.
DOI: 10.6084/m9.figshare.13978751
title: Additional file 1 of Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

description: Additional file 1: Sheet 1. Summary of datasets used in the study. Sheet 2. Marker genes of 28 immune cells. Sheet 3. Marker genes of TILCs. Sheet 4. Marker genes of TIS score. Sheet 5. GSEA result of FCER1G high vs low subgroups.
DOI: 10.6084/m9.figshare.13978751.v1
title: Additional file 1 of Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

description: Additional file 1: Sheet 1. Summary of datasets used in the study. Sheet 2. Marker genes of 28 immune cells. Sheet 3. Marker genes of TILCs. Sheet 4. Marker genes of TIS score. Sheet 5. GSEA result of FCER1G high vs low subgroups.
DOI: 10.6084/m9.figshare.13978750
title: Additional file 1 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 1: Table S1. In-process data for working cell banks of hBM-MSCs used in this study.
DOI: 10.6084/m9.figshare.13978759
title: Additional file 3 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 3: Table S3. Nanoparticle tracking analysis summary data of EVs derived from four hBM-MSC donors at the three collection time points.
DOI: 10.6084/m9.figshare.13978753
title: Additional file 2 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 2: Table S2. Nanoparticle and protein concentration data analyzed for extracellular vesicles processed for lectin microarray analysis.
DOI: 10.6084/m9.figshare.13978753.v1
title: Additional file 2 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 2: Table S2. Nanoparticle and protein concentration data analyzed for extracellular vesicles processed for lectin microarray analysis.
DOI: 10.6084/m9.figshare.13978750.v1
title: Additional file 1 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 1: Table S1. In-process data for working cell banks of hBM-MSCs used in this study.
DOI: 10.6084/m9.figshare.13978765.v1
title: Additional file 4 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 4: Table S4. 37-bead multiplex surface epitope analysis of EVs from hBM-MSCs shows maintenance of MSC and EV specific markers over 25 days of EV production as well as presence of immune-related antigens.
DOI: 10.6084/m9.figshare.13978771
title: Additional file 6 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 6: Figure S1. Immunophenotypic analysis of bioreactor-harvested hBM-MSCs confirms a low positive expression of CD34 antigen, but not HLA-DR. a) Flow cytometric analysis of CD34 and HLA-DR antigens from bioreactor-harvested hBM-MSCs from donors hBM-MSC-48RB/81RB/55RB/85RB. Red indicates the cell population stained with the respective antibodies. Blue indicates the cells stained with an IgG isotype control. b) Quantification of the percentage of positive cells analyzed by flow cytometry. Figure S2. EV production from hBM-MSCs in the hollow-fiber cell bioreactor system yields nanovesicles of small EV size distribution profile. a) The mode (i), mean (ii) and the concentration (iii) of EVs are represented for the four hBM-MSC donors (N = 4 donors; hBM-MSC-48RB/81RB/55RB/85RB donors) at 3 different time points (days 1, 3 and 25). Each dot represents 5 technical replicates from each the four hBM-MSC donors (hBM-MSC-48RB/81RB/55RB/85RB donors). Figure S3. a) FPLC injection of 50mL of TFF diafiltrated EV-rich cell conditioned medium (CCM) pooled from 5mL aliquots of CCM harvested each day from the hollow-fiber system from days 1-25 (5mL X 25 days of production) was performed using HiScreen CaptoCore 700 column for EV purification followed by Cleaning In Place (CIP) elution of CCM contamination. The CCM used in this analysis was obtained from donor #hBM-MSC-81RB. EV collection occurred once the UV baseline began to rise indicated by the fraction markers in red. Fractionation was stopped and switched to waste once the UV peak began to fall. CIP was conducted after fractionation to determine the amount of contaminates removed as indicated by the single peak. These data represent n=1 experiment using n=1 donor sample (#hBM‑MSC-81RB). b) Nanoparticle tracking analysis (NTA) of the pooled FPLC fractions containing EVs purified by FLPC. Each dot represents 5 technical replicates of donor sample #hBM-MSC-81RB. c) Flow cytometric validation of the pooled FPLC fractions containing EVs show CD63-bead purified EVs followed by detection with anti-CD63/CD81/CD9‑APC antibody cocktail, as indicated in blue. The unstained CD63‑bead purified EVs control (no APC antibody cocktail detection) is shown in red and was used to set the negative population. These data represent n=1 experiment using n=1 donor sample (#hBM‑MSC-81RB). Figure S4. Transmission electron microscopy (TEM) analysis confirmed the presence of small EVs. EVs from hBM-MSC donor 55RB were assessed by TEM which showed expected morphology and size of small EVs (
DOI: 10.6084/m9.figshare.13978765
title: Additional file 4 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 4: Table S4. 37-bead multiplex surface epitope analysis of EVs from hBM-MSCs shows maintenance of MSC and EV specific markers over 25 days of EV production as well as presence of immune-related antigens.
DOI: 10.6084/m9.figshare.13978759.v1
title: Additional file 3 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 3: Table S3. Nanoparticle tracking analysis summary data of EVs derived from four hBM-MSC donors at the three collection time points.
DOI: 10.6084/m9.figshare.13978768.v1
title: Additional file 5 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 5: Table S5. Analysis of EV samples using the MILLIPLEX MAP human cytokine/chemokine magnetic bead assay.
DOI: 10.6084/m9.figshare.13978771.v1
title: Additional file 6 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 6: Figure S1. Immunophenotypic analysis of bioreactor-harvested hBM-MSCs confirms a low positive expression of CD34 antigen, but not HLA-DR. a) Flow cytometric analysis of CD34 and HLA-DR antigens from bioreactor-harvested hBM-MSCs from donors hBM-MSC-48RB/81RB/55RB/85RB. Red indicates the cell population stained with the respective antibodies. Blue indicates the cells stained with an IgG isotype control. b) Quantification of the percentage of positive cells analyzed by flow cytometry. Figure S2. EV production from hBM-MSCs in the hollow-fiber cell bioreactor system yields nanovesicles of small EV size distribution profile. a) The mode (i), mean (ii) and the concentration (iii) of EVs are represented for the four hBM-MSC donors (N = 4 donors; hBM-MSC-48RB/81RB/55RB/85RB donors) at 3 different time points (days 1, 3 and 25). Each dot represents 5 technical replicates from each the four hBM-MSC donors (hBM-MSC-48RB/81RB/55RB/85RB donors). Figure S3. a) FPLC injection of 50mL of TFF diafiltrated EV-rich cell conditioned medium (CCM) pooled from 5mL aliquots of CCM harvested each day from the hollow-fiber system from days 1-25 (5mL X 25 days of production) was performed using HiScreen CaptoCore 700 column for EV purification followed by Cleaning In Place (CIP) elution of CCM contamination. The CCM used in this analysis was obtained from donor #hBM-MSC-81RB. EV collection occurred once the UV baseline began to rise indicated by the fraction markers in red. Fractionation was stopped and switched to waste once the UV peak began to fall. CIP was conducted after fractionation to determine the amount of contaminates removed as indicated by the single peak. These data represent n=1 experiment using n=1 donor sample (#hBM‑MSC-81RB). b) Nanoparticle tracking analysis (NTA) of the pooled FPLC fractions containing EVs purified by FLPC. Each dot represents 5 technical replicates of donor sample #hBM-MSC-81RB. c) Flow cytometric validation of the pooled FPLC fractions containing EVs show CD63-bead purified EVs followed by detection with anti-CD63/CD81/CD9‑APC antibody cocktail, as indicated in blue. The unstained CD63‑bead purified EVs control (no APC antibody cocktail detection) is shown in red and was used to set the negative population. These data represent n=1 experiment using n=1 donor sample (#hBM‑MSC-81RB). Figure S4. Transmission electron microscopy (TEM) analysis confirmed the presence of small EVs. EVs from hBM-MSC donor 55RB were assessed by TEM which showed expected morphology and size of small EVs (
DOI: 10.6084/m9.figshare.13978768
title: Additional file 5 of Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell

description: Additional file 5: Table S5. Analysis of EV samples using the MILLIPLEX MAP human cytokine/chemokine magnetic bead assay.
DOI: 10.6084/m9.figshare.13978859
title: Additional file 1 of The acceptability and feasibility of a pilot study examining the impact of a mobile technology-based intervention informed by behavioral economics to improve HIV knowledge and testing frequency among Latinx sexual minority men and transgender women

description: Additional file 1.
DOI: 10.6084/m9.figshare.13978859.v1
title: Additional file 1 of The acceptability and feasibility of a pilot study examining the impact of a mobile technology-based intervention informed by behavioral economics to improve HIV knowledge and testing frequency among Latinx sexual minority men and transgender women

description: Additional file 1.
DOI: 10.6084/m9.figshare.13978874
title: Additional file 2 of 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells

description: Additional file 2: Table S1. N-glycans and features from secreted glycoproteins from all cell lines.
DOI: 10.6084/m9.figshare.13978877.v1
title: Additional file 3 of 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells

description: Additional file 3: Table S2. Detailed assignments of N-glycans from cell glycoproteins of A2780 cell line using UPLC and exoglycosidase digestions.
DOI: 10.6084/m9.figshare.13978874.v1
title: Additional file 2 of 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells

description: Additional file 2: Table S1. N-glycans and features from secreted glycoproteins from all cell lines.
DOI: 10.6084/m9.figshare.13978877
title: Additional file 3 of 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells

description: Additional file 3: Table S2. Detailed assignments of N-glycans from cell glycoproteins of A2780 cell line using UPLC and exoglycosidase digestions.